SCOPUS 정보 검색 플랫폼

Volumn 36, Issue 1, 2001, Pages 19-25

Novel erythropoiesis-stimulating protein: An erythropoietin analogue with an extended half-life and less frequent dosing

(1) Joy, M S a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; AREA UNDER THE CURVE; CANCER CHEMOTHERAPY; CHILD; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HALF LIFE; DRUG POTENTIATION; DYSPNEA; FOOD AND DRUG ADMINISTRATION; GASTROINTESTINAL SYMPTOM; HEALTH INSURANCE; HEMODIALYSIS; HUMAN; REVIEW; THROMBOSIS;

EID: 0035155782 PISSN: 1082801X EISSN: None Source Type: Journal
DOI: None Document Type: Review

Times cited : (5)

References (31)

1
- 0032134385
- Excerpts from United States Renal Data System: 1998 Annual Data Report
- (1998) Am J Kidney Dis , vol.32 , Issue.2 SUPPL. 1

2
- 0001817480
- Updates in chronic renal failure and hemodialysis
- Pharmacotherapy Self-Assessment Program. 3rd ed. Carter BL, et al, eds. Kansas City, MO: American College of Clinical Pharmacy
- (1999) , pp. 1-48
- Stamatakis, M.K.¹ Joy, M.S.²

3
- 0002929285
- Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy
- (1995) Cancer J Sci Am , vol.1 , pp. 252-260
- Henry, D.H.¹ Brooks B.J., Jr.² Case D.C., Jr.³

4
- 0030921662
- NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative
- (1997) Am J Kidney Dis , vol.30 , Issue.SUPPL. 3

5
- 0242611254
- Cloning and expression of the human erythropoietin gene
- (1985) Proc Natl Acad Sci USA , vol.82 , pp. 7580-7584
- Lin, F.-K.¹ Suggs, S.² Lin, C.-H.³

6
- 0000212930
- The role of carbohydrate on the biological activity of erythropoietin
- Abstract S7.7
- (1993) Glycoconj J , vol.10 , pp. 263
- Egrie, J.C.¹ Grant, J.R.² Gillies, D.K.³

7
- 0002418073
- Novel erythropoiesis stimulating protein (NESP) has a longer serum half-life and greater in vivo biological activity than recombinant human erythropoietin (rHuEPO)
- Abstract 243
- (1997) Blood , vol.90 , Issue.10 SUPPL. 1
- Egrie, J.C.¹ Dwyer, E.² Lykos, M.³

8
- 0023837516
- Peritubular cells are the site of erythropoietin synthesis in the murine hypoxic kidney
- (1988) J Clin Invest , vol.81 , pp. 620-623
- Lacombe, C.¹ Da Silva, J.-L.² Bruneval, P.³

9
- 0025912710
- Localization of cells producing erythropoietin in murine liver by in situ hybridization
- (1991) Blood , vol.77 , pp. 2497-2503
- Koury, S.T.¹ Bondurant, M.C.² Koury, M.J.³ Semenza, G.L.⁴

10
- 0025321673
- Clinical pharmacology of recombinant human erythropoietin (r-HuEPO)
- (1990) Pharmacotherapy , vol.10 , Issue.2 PART 2
- Flaharty, K.K.¹

11
- 0032737391
- Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients
- (1999) J Am Soc Nephrol , vol.10 , pp. 2392-2395
- Macdougall, I.C.¹ Gray, S.J.² Elston, O.³

12
- 0000488626
- The pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in pediatric patients with chronic renal failure (CRF) or end-stage renal disease
- Abstract
- (2000) J Am Soc Nephrol , vol.11 , Issue.SUPPL.
- Lerner, G.R.¹ Kale, A.S.² Warady, B.A.³

13
- 0027310385
- Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis
- (1993) Am J Kidney Dis , vol.21 , pp. 635-642
- Ateshkadi, A.¹ Johnson, C.A.² Oxton, L.L.³

14
- 0025986687
- Pharmacokinetics of recombinant human erythropoietin in children with renal failure
- (1991) Nephrol Dial Transplant , vol.6 , pp. 709-714
- Evans, J.H.C.¹ Brocklebank, J.T.² Bowmer, C.J.³ Ng, P.C.⁴

15
- 0006420996
- Presented at: American Society of Clinical Oncology 36th annual meeting; May 2000; New Orleans, LA. Abstract 210
- (2000) 1/2) in oncology patients
- Glaspy, J.¹ Colowick, A.² Heatherington, A.³

16
- 0001545680
- The pharmacokinetics of novel erythropoiesis stimulating protein (NESP) following chronic intravenous administration is time- and dose-linear
- Abstract
- (2000) J Am Soc Nephrol , vol.11 , Issue.SUPPL.
- Allon, M.¹ Kleinman, K.² Walczyk, M.³

17
- 0000206617
- Novel erythropoiesis stimulating protein (NESP) for the treatment of renal anaemia
- Abstract M383
- (1998) J Am Soc Nephrol , vol.9 , Issue.SUPPL.
- Macdougall, I.C.¹

18
- 0001724535
- Novel erythropoiesis stimulating protein (NESP) corrects anemia in dialysis patients when administered at reduced dose frequency compared with recombinant-human erythropoietin (r-HuEPO)
- Abstract
- (2000) J Am Soc Nephrol , vol.11 , Issue.SUPPL.
- Coyne, D.¹ Ling, B.N.² Toto, R.³

19
- 0000203171
- Novel erythropoiesis stimulating protein (NESP) maintains hemoglobin (Hgb) in ESRD patients when administered once weekly or once every other week
- Abstract
- (1999) J Am Soc Nephrol , vol.10 , Issue.SUPPL.
- Vanrenterghem, Y.¹ Barany, P.² Mann, J.³

20
- 0000238060
- Novel erythropoiesis stimulating protein (NESP) administered subcutaneously corrects anemia in subjects with chronic renal insufficiency (CRI) when administered at a reduced dose frequency compared with recombinant-human erythropoietin (r-HuEPO)
- Abstract
- (2000) J Am Soc Nephrol , vol.11 , Issue.SUPPL.
- Locatelli, F.¹ Olivares, J.² Walker, R.³ Wilkie, M.⁴

21
- 0001524646
- Novel erythropoiesis stimulating protein (NESP) safely maintains hemoglobin concentration levels in hemodialysis patients as effectively as r-HuEPO when administered once weekly
- Abstract
- (2000) J Am Soc Nephrol , vol.11 , Issue.SUPPL.
- Nissenson, A.R.¹ Swan, S.K.² Lindberg, J.S.³

22
- 0000978972
- Novel erythropoiesis stimulating protein (NESP) effectively maintains hemoglobin (Hgb) when administered at a reduced dose frequency compared with recombinant human erythropoietin (r-HuEPO) in ESRD patients
- Abstract
- (2000) J Am Soc Nephrol , vol.11 , Issue.SUPPL.
- Graf, H.¹ Lacombe, J.-L.² Braun, J.³ Gomes da Costa, A.A.⁴

23
- 0006456301
- Randomized, active-controlled phase I/II dose escalation study of novel erythropoiesis stimulating protein (NESP) in patients with solid tumours
- Abstract 6670
- (2000) Ann Oncol , vol.11 , Issue.SUPPL. , pp. 146
- Glaspy, J.¹ Obyrne, J.² Armstrong, S.³ Coldwick, A.⁴

24
- 0033913634
- Novel erythropoiesis stimulating protein
- (2000) Semin Nephrol , vol.20 , pp. 375-381
- Macdougall, I.C.¹

25
- 0028153345
- Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis
- (1994) Kidney Int , vol.46 , pp. 1397-1403
- Julian, B.A.¹ Gaston, R.S.² Barker, C.V.³

26
- 0024393650
- Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients
- (1989) J Cardiovasc Pharmacol , vol.13 , Issue.SUPPL. 3
- Onoyama, K.¹ Sanai, T.² Motomura, K.³ Fujishima, M.⁴

27
- 0034042547
- ACE inhibitors do not induce recombinant human erythropoietin resistance in hemodialysis patients
- (2000) Am J Kidney Dis , vol.35 , pp. 1076-1082
- Abu-Alfa, A.K.¹ Cruz, D.² Perazella, M.A.³

28
- 0031971365
- Potential angiotensin-converting enzyme inhibitor-epoetin alfa interaction in patients receiving chronic hemodialysis
- (1998) Pharmacotherapy , vol.18 , pp. 627-630
- Schwenk, M.H.¹ Jumani, A.Q.² Rosenberg, C.R.³

29
- 0029819150
- Angiontensin-converting enzyme inhibitor therapy in chronic hemodialysis patients: Any evidence of erythropoietin resistance?
- (1996) Am J Kidney Dis , vol.28 , pp. 535-540
- Cruz, D.N.¹ Perazella, M.A.² Abu-Alfa, A.K.³ Mahnensmith, R.L.⁴

30
- 0028008866
- High hematocrit in haemodialysis patients can be controlled by theophylline administration
- (1994) Nephrol Dial Transplant , vol.9 , pp. 189-191
- Vereerstraeten, A.¹ Gastaldello, K.² Gervy, C.³

31
- 0025057941
- Amphotericin B blunts erythropoietin response to anemia
- (1990) J Infect Dis , vol.161 , pp. 348-351
- Lin, A.C.¹ Goldwasser, E.² Bernard, E.M.³ Chapman, S.W.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.